Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06171269

Using MRI to Identify Areas to Receive Lower Doses of Radiation Treatment in Men With Prostate Cancerdose Mapping to Preserve Quality of Life

A Prospective Study of Lower Dose Radiation (LO-RADS) for Prostate Cancer Using MRI Dose Mapping to Preserve Quality of Life

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
University of Chicago · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research is to gather information on the safety and effectiveness of using an imaging technique called magnetic resonance imaging (MRI) to decrease radiation dose to the uninvolved prostate (areas of the prostate that do not clearly have cancer cells) while increasing radiation dose to the nodules (hardened areas of the prostate that have cancer cells).

Conditions

Interventions

TypeNameDescription
RADIATIONRadiationRadiation to the prostate gland will be given daily (Mon-Friday) for 4 weeks.
RADIATIONMRIThe study doctor will use an MRI scan to take pictures of the prostate gland. These images of the prostate gland will let the study doctor know which areas of the prostate contain cancer cells that need to be targeted with higher doses of radiation and which uninvolved areas to target with lower doses of radiation.
OTHERAndrogen Deprivation TherapyTreatment of treating physician choice will be given for 6-24 months.

Timeline

Start date
2024-01-05
Primary completion
2027-02-14
Completion
2028-10-20
First posted
2023-12-14
Last updated
2026-03-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06171269. Inclusion in this directory is not an endorsement.